Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04641247
Title A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

ovarian cancer

breast cancer

Therapies

Niraparib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN | AUT

Facility Status City State Zip Country Details
GSK Investigational Site Tucson Arizona 85710 United States Details
GSK Investigational Site West Hollywood California 90048 United States Details
GSK Investigational Site Whittier California 90603 United States Details
GSK Investigational Site Jacksonville Florida 32224 United States Details
GSK Investigational Site Atlanta Georgia 30342 United States Details
GSK Investigational Site Harvey Illinois 60426 United States Details
GSK Investigational Site Boston Massachusetts 02115 United States Details
GSK Investigational Site Morristown New Jersey 07962-1956 United States Details
GSK Investigational Site Lake Success New York 11042 United States Details
GSK Investigational Site Charlotte North Carolina 28204 United States Details
GSK Investigational Site Cleveland Ohio 44195 United States Details
GSK Investigational Site Graz A-8036 Austria Details
GSK Investigational Site Wien 1090 Austria Details
GSK Investigational Site Vancouver British Columbia V5Z 4E6 Canada Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Montreal Quebec H4A 3J1 Canada Details
GSK Investigational Site Odense 5000 Denmark Details
GSK Investigational Site Nantes cedex 44202 France Details
GSK Investigational Site Nice Cedex 2 06189 France Details
GSK Investigational Site Haifa 3109601 Israel Details
GSK Investigational Site Cremona Lombardia 26100 Italy Details
GSK Investigational Site Madrid 28046 Spain Details
GSK Investigational Site Marid 28040 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field